Dr. Nork’s laboratory concentrates on understanding the mechanisms underlying photoreceptor injury, and whether excitotoxic activity is responsible for loss of retinal ganglion cells in glaucoma. The concepts discovered in the Nork Lab provide important information for the treatment of open-angle glaucoma and prevention of visual loss from glaucomatous neurodegeneration, as well as the basic scientific understanding of the functioning of these neurons in health and disease. This novel work has implications for injury in stroke and many other ischemic neurologic conditions.
Nork Lab Members
Michael Nork, MD, MS, FARVO
James Ver Hoeve, MS, PhD
Credentials: Senior Scientist Emeritus
Charlene Kim, PhD
Credentials: Associate Scientist
Credentials: Research Specialist